Please login to the form below

Not currently logged in

breakthrough therapy

This page shows the latest breakthrough therapy news and features for those working in and with pharma, biotech and healthcare.

J&J bags FDA breakthrough designation for prostate cancer drug

J&J bags FDA breakthrough designation for prostate cancer drug

Could challenge rival PARP inhibitor Lynparza. The FDA has granted Johnson &Johnson's PARP inhibitor niraparib a breakthrough therapy designation (BTD) in prostate cancer, helping it to make gains on rival ... We are pleased with the FDA’s Breakthrough

Latest news

More from news
Approximately 10 fully matching, plus 81 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Empowering Strategic Performance Ltd

Empowering Strategic Performance helps clients Metamorph™ Science into Action that changes healthcare so improving the lives of patients. We help...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...